Introducing our newly upgraded CKD Screening Prioritizer webpage.
We're thrilled to announce a major revamp of our product page.
Visit https://t.co/0fRLUDZGiS to explore our new look
#HealthTech#ProductPageUpgrade
We are thrilled to share that our CKD Screening Prioritizer, has not only met but exceeded
@OrchaHealth's quality threshold by achieving an outstanding score of 89%
demonstrating excellence in Data, Usability & Accessibility and Professional Assurance
https://t.co/hdZVtzMU8G
We're delighted to be exhibiting at #HETT23 tomorrow at @ExCeLLondon .
Register for your free pass to join the event https://t.co/GTHtnuMmZR
Find us in the @AHSNNetwork Innovation Zone
Gendius were invited to attend the parliamentary launch of @Kidney_Research's new health economics report.
It was great to hear from @NHSEnglandNMD, Andy Cole and many others supporting the campaign to raise kidney disease up the political agenda
#CKD#NHS#HealthTech
Our CKD Screening Prioritizer (CSP) is officially a registered medical device!
This UKCA mark signifies not only a sign of credibility but allows the expansion of our CSP product into the UK market.
Read more about this accomplishment here: https://t.co/aedzrLrjQS
#UKCA#CKD
There is still time to apply for this exciting Programme Manager position 👇
The role will involve collaboration with colleagues in partner organisations such as universities, NHS partners, industry & other key stakeholders 🤝
🔗https://t.co/PU5ldx8qTf #NHSJobs
Great to see our most recent research working at @Gendiushealth getting some attention. CKD is a growing problem and we need solutions that support early identification to prevent progression to end stage disease. Shout out to the incredible @rosesisk leading this research!
Our Co-Founder, Chris Genders speaking on the Algorithms and Artificial Intelligence panel as part of the GM Health Innovation Accelerator Programme Launch
#Manchester#innovation
‘Algorithms and Artificial Intelligence’ will now feature with discussions held by @Gendiushealth and @jivaAI
“We can really embrace the opportunity that technology has”
#weareHInM
Jay Hamilton (@healthinnovmcr Programme Director of Industry & Commercial Partnerships) takes us through:
👉CKD risk stratification
👉 Lipids management
👉 Remote Spirometry
#weareHInM
We are live at the GM Health Innovation Accelerator Programme Launch! 🎉
Earlier this year, the new multi-million pound HIA was announced, which is to focus on rapidly improving the diagnosis & treatment of disease across the GM population
🔗 https://t.co/FvJI4aq0B7
What a difference a year makes!
From 28th to 4th, this year the Gendius team ranked higher than ever in the @BCloudUK MedTech50
You can see the full 2023 ranking of the UK's most innovative medical technology creators here
https://t.co/dozKQc40yf
#MedTech50#UK#innovation
The Gendius team has had a great time at the #PCDE2023 conference.
Presenting our latest work and connecting with international primary care professionals.
A great step forward in understanding how our digital solutions can help embellish primary care systems globally
#PCDE23
If you missed @rosesisk presenting her latest work on Diagnosis coding of Chronic Kidney Disease (CKD) in Type 2 Diabetes earlier @PCDEurope
The key findings are summarised below, or you can find the full preprint here https://t.co/6rhFSGE09H
#CKD#T2D#PrimaryCare#PCDE2023
This morning we presented our poster on the consistency of eGFR-based CKD and diagnosis coding in type 2 diabetes in UK primary care at #PCDE2023
Very grateful to be here with the @Gendiushealth team @Claudia_Sarah_ and @cjmspowell